What types of companies should be avoided, and which stand to benefit from the end of the easy money era
More Videos
“Value Creators and Price Takers” - Investing in Healthcare Today (4:42)
Why we don't bet on blockbuster drug approvals - focusing instead on durable companies that are helping to manage costs across the healthcare system
Watch Now
The Return to Rationality
The bursting of the easy money bubble marks a huge transition for the markets
Watch Now
